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Objectives: to assess a new method of determining functional impairment in patients with intermittent claudication,
the Double Physiological Walking Test (DPWT) using the PADHOC (Peripheral Arterial Disease Holter Control) device,
against a standard treadmill test.
Design: patients with intermittent claudication presenting to the department were considered for both the DPWT and a
standard treadmill test.
Methods: initial claudicating distance, maximal walking distance and speed of walking were determined for both parts
of the DPWT. Initial claudicating distance and maximal walking distance were determined from the treadmill test.
Comparisons were made between the treadmill test and the DPWT.
Results: the treadmill test was unable to be performed in 22% of patients due to defined contraindications. There were
strong correlations in both walking distances and disease severity when comparing the DPWT and the treadmill test.
Patients in whom the treadmill test was contraindicated had significantly shorter walking distances on the DPWT than
those who were able to complete a treadmill walking test.
Conclusions: the DPWT correlates strongly with walking distances obtained from a standard treadmill test. However,
the PADHOC can be used in a number of differing locations and settings as well as in patients in whom a treadmill test
is contraindicated. It therefore has a role to play in the initial assessment of patients presenting with intermittent
claudication.
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Introduction initial outlay for a machine is great and the test is
restricted to a predominantly laboratory based setting.
Furthermore it does not actually measure the func-The most common symptom in patients with peri-
tional incapacity experienced by the patient on a day-pheral vascular disease is intermittent claudication.
to-day basis with both the speed and gradient beingClaudication distance is used in addition to ankle
kept artificially constant.pressure measurements as a marker of disease severity.
In an effort to overcome these limitations, otherHowever, claudication distances can be both spuri-
methods of assessment of walking distance have beenously estimated and inaccurately reported.1 Fur-
advocated. The graded treadmill test, the Stresst’erthermore, conventional objective assessments of
ergometer and the 6 m walking test have been pro-peripheral vascular disease, such as ankle and toe
posed, but there are a number of limitations with eachpressure measurements correlate poorly with walking
of these tests.3,5,6,8 It was because of these shortcomingsability in patients with intermittent claudication.2
that a new device has been developed to allow phys-The ‘‘gold standard’’ laboratory test is still the Con-
icians a more accurate reflection of the daily functionalstant Load Treadmill Test (CLTT).3 However, in many
incapacity experienced by the claudicant. The deviceinstances, patients with intermittent claudication have
is known as the PADHOC (Peripheral Arterial Diseasecontraindications to undergoing standardised tread-
Holter Control Device), and it allows the measurementmill testing.3,4 As a result, a number of differing tread-
of various components of a patients gait in an out-mill protocols have emerged, which has limited the
patient setting. It has been designed to be a lessopportunity for comparison between studies.3,5–7
artificial measurement of the actual incapacity ex-The treadmill test has a number of limitations. The
perienced by patients under ‘‘normal’’ everyday con-
ditions (i.e. walking on level ground and at the patients
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Table 1. Advantages of the PADHOC. that records the data. It is connected to two ultrasound
sensors (a transmitter sensor and a receiver sensor),The test does not have to be performed in a hospital setting.
The test measures the actual incapacity experienced by the each fixed over the patient’s medial malleoli by ankle
claudicant. straps, and to a control module held in the patient’s
It is not subject to interference from arm support. hand. The test is performed indoors on level ground.There is no preset constant workload against which the patient
has to exercise against. As the patient commences walking, they press the
There is no ceiling or floor affect as has been found by some green button. At the onset of claudication pain, the
methods of testing. patient presses the yellow button and the red button
is then pressed when the patient can walk no further.clinical practice as an assessment tool for patients with
The patient then rests, standing for one minute, andintermittent claudication it is necessary to determine
the test is then repeated. For each test ICD, MWD andhow it compares with other methods of assessment
speed are calculated and the whole test is known asof disease severity. Due to the limitations of other
the Double Physiological Walking Test (DPWT). Thepreviously used devices, the treadmill is still the most
belt pack receives and processes the signal and displayswidely used and validated method of assessing
the results on a LED screen. The device has a numberpatients claudication distances and is therefore the
of advantages (Table 1).most appropriate tool to use for comparison.
The aim of this study was to compare the PADHOC
device with a standard constant load treadmill assess-
ment in a group of patients with intermittent clau-
Principle of the PADHOC devicedication and to compare patients own assessment of
walking distance with that measured using the Double
The measurement principle of the PADHOC device isPhysiological Walking Test. Furthermore, we wished
based upon ultrasound telemetry. Walking distanceto determine differences in walking characteristics be-
is calculated by the continuous measurement of thetween patients who were able and unable to perform
distance between the patients medial malleoli. Thea treadmill test.
transmitting sensor sends an ultrasound signal to the
receiver sensor 64 times a second. The main unit
Patients and Methods measures the time taken for the signal to travel from
one sensor to the other. The distance between the
Sixty-three patients with intermittent claudication (36 medial malleoli is calculated by multiplying this time
men, 27 women; median age 69 years, range 48–86 by the sound propagation speed. All measurements
years) were enrolled into this study that had local of this distance are plotted as a sinusoidal curve.
ethical group approval. All the patients recruited to Each oscillation on the curve corresponds to one step.
this study had been invited to take part in a prospective Maximum variations correspond to the moment when
study being undertaken by the department de- both feet touch the ground. Therefore, each maximum
termining the effect of different treatment modalities in variation represents the actual walking distance trav-
claudicants. All patients had symptoms of claudication elled during one step. The sum of all the maximum
with duplex or angiographically proven vascular dis- intermalleolar distances is used to calculate the walk-
ease. Table 2 shows the co-morbidity of the population ing distance. This allows the parameters ICD, MWD
as determined by recognised SVS/ISCVS criteria.9 The and walking speed to be measured for both parts of
patients own estimated claudication distance was the DPWT.
noted initially and the ankle brachial pressure indices
(ABPI’s) determined following a period of 45 min rest
using a standard technique.10 Both tests were per-
formed on the same day with a 1-hour rest period Principle of the Double Physiological Walking Tests with
between them. ICD and MWD were determined from the PADHOC System (Fig. 2)
the treadmill test and disease severity classified as
either mild, moderate or severe claudication based During the walking test, the pain that causes the
upon SVS/ISCVS criteria.9 patient to stop is thought to occur at the same time as
the decrease in ankle pressure.11 The speed at which
the ankle pressure recovers to its initial pre-exerciseThe PADHOC device (Fig. 1)
value varies according to the functional state of the
collateral circulation. After the patient has rested,The device consists of a main unit worn by the patient,
on a belt, which contains a removable computer card standing, for one minute the pain subsides but the
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Table 2. Co-morbidity of the claudicant population as determined by the SVS/ISCVS criteria.9
SVS/ISCVS
Classification 0 1 2 3
Diabetes 45 5 3 —
Smoking 23 15 23 2
Hypertension 37 17 6 3
Cardiac 45 3 13 2
Carotid 53 3 4 3
Pulmonary 47 15 1 —
Number of patients.
Fig. 2. Representation of the principle behind the Double Physio-
logical Walking Test. MWD: Maximum walking distance. (–––) good
collateral recovery; (–––) poor collateral recovery.
The constant load treadmill test
The patients were placed on a treadmill with the speed
and incline standardised (2.5 km/h at an incline of 10°
for a maximum of 5 min).7 The initial claudication
and maximum claudication distances were noted. Post
exercise ABPIs were then determined immediately
after the end of the test. Disease severity was de-Fig. 1. The main unit worn by the patient.
termined using SVS/ISCVS criteria.9
ankle pressure may still remain at a lower value than
that prior to the initial walking period. It would seem
reasonable that the longer time it takes for the ankle Statistical analysis
pressure to recover to its original value, the shorter
a second walking test carried out under the same All data is represented as median (interquartile range).
Data was analysed for correlation using the Spearmanconditions will be. Using this principle, disease se-
verity can be measured by determining distance ratios rank correlation coefficient. Non-parametric analysis
was used to analyse data from within groups (Wil-for both ICD and MWD between the first and second
walking tests (ICD2/ICD1 and MWD2/MWD1 re- coxon signed ranks test) and between groups (Mann–
Whitney U-test). p<0.05 was considered statisticallyspectively), with lower values representing more
severe disease. significant.
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Results paring the patients who were and were not able to
complete a treadmill test (Table 3). There was no
All patients underwent the DPWT with only 49 significant difference in the initial claudication distance
between the two groups for the second part of thepatients (78%) undergoing the standard treadmill test.
The reasons for failure to complete the treadmill test DPWT. There were also no significant differences be-
tween the ratios for both ICD and MWD obtained forwere ischaemic heart disease in 7, chronic obstructive
pulmonary disease in 6 and osteoarthritis in 1. There the two groups.
was no significant difference in resting ABPI’s between
those able and those not able to complete the treadmill
test (0.75 (0.53–0.81) vs 0.72 (0.5–0.85) p>0.05 Mann–
DiscussionWhitney U-test). In those patients who completed the
treadmill test, the post exercise ABPI was significantly
The decision to intervene in a patient with intermittentlower than the initial resting ABPI (0.45 (0.24–0.69) vs
claudication is based on a number of factors including0.72 (0.5–0.85) p<0.01 Wilcoxon signed ranks test). Of
the patient’s quality of life and overall walking dis-the 49 claudicants who underwent treadmill testing,
tance. Estimated claudication distances are thought to6 were mild claudicants, 25 were moderate claudicants
be inaccurate,1 and therefore accurate assessment ofand 18 were severe claudicants as determined using
a patient’s everyday walking ability is important.1,12SVS/ISCVS criteria.9
For many years, the treadmill test has been usedClaudicants who were unable to complete a tread-
as the gold standard test for determining walkingmill test had lower estimated claudication distances
distances. However, it does not represent the func-than the patients who were able to complete a treadmill
tional incapacity experienced by the patient on a daytest (50 m (50 m–112.5 m) vs 150 m (57.5 m–262.5 m);
to day basis, as both the speed and gradient are keptp=0.05 Mann–Whitney U-test).
artificially constant.13 The claudicant population is alsoThere was no significant difference between es-
heterogeneous in nature with marked variability intimated claudication distances and actual claudication
co-morbidity. This produces a number of potentialdistances as measured by the first part of the DPWT
problems with using the treadmill to assess functionalin either group of patients (p=0.88 no treadmill test;
incapacity. Indeed a number of studies have reportedp=0.20 treadmill test; Wilcoxon signed ranks test).
that between 20% and 46% of claudicants are unableIndeed, there was a strong correlation between the
to perform a treadmill test.4,5,14 The reasons for this arepatients estimated claudication distance and the tread-
usually the speed of the treadmill or significant co-mill ICD (r=0.49; p<0.01) and the initial PADHOC
morbidity (usually ischaemic heart disease, congestiveICD (r=0.50; p<0.01) in those claudicants who were
cardiac failure, chronic obstructive pulmonary diseaseable to complete a treadmill test.There was a strong
or osteo-arthritis – conditions that contra-indicate acorrelation between the maximum treadmill walking
treadmill test being performed). In our study, 22%distance and the maximum walking distances of both
of the enrolled patients were unable to undertake aparts of the DPWT (MWD1 r=0.60, p<0.01; MWD2 r=
treadmill test mainly due to cardiac and pulmonary0.50, p<0.01: Figs 3 and 4). There was also strong
problems.correlation between the treadmill initial claudication
Over the last decade, further methods and devicesdistance and the initial claudication distances obtained
have been to determine disease severity in patientsfrom the first part of the DPWT (r=0.61, p<0.01: Fig. 5).
with intermittent claudication. These include theHowever, there was no significant correlation between
graded treadmill test, the 6-min walking test and thethe treadmill initial claudication distance and the initial
Stresst’er ergometer.3,5,8claudication distances obtained from the second part
The problems encountered with the graded tread-of the DPWT (r=0.15, p>0.05). There was a significant
mill test are similar to those found with the constantcorrelation in disease severity as determined using the
load treadmill test. The 6-min walking test was adaptedDPWT (ICD2/ICD1 and MWD2/MWD1) with disease
from similar tests developed for patients with con-severity determined using the treadmill test (SVS/
gestive heart failure and chronic obstructive pul-ISCVS criteria) (ICD2/ICD1 r=−0.32, p=0.03;
monary disease15,16 and it has been found to be highlyMWD2/MWD1 r=−0.31, p=0.04). Notably, there was
reliable, simple and easy to administer in claudicants.16no correlation between the resting ABPI’s and the
It has been suggested that the submaximal exercise ofwalking ratios ICD2/ICD1 and MWD2/MWD1.
the 6-min walking test was more representative of theThere were significant differences in walking speeds,
usual activities of daily living. However, it also has amaximum walking distances and the initial clau-
dication distance of the first walking test when com- number of limitations including the fact that the test
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Fig. 3. Scattergraph comparing the PADHOC maximum walking distance from the first part of the DPWT to the treadmill maximum
walking distance.
Fig. 4. Scattergraph comparing the PADHOC maximum walking distance from the second part of the DPWT to the treadmill maximum
walking distance.
needs to be followed rigidly so as to elicit reliable distances are affected by their claudication using this
device.results. More recently, the Stresst’er ergometer has
been put forward as a possible alternative to the It was because of all the limitations listed above that
the PADHOC device was developed.11 The PADHOCtreadmill test.3 It has been found to correlate with the
treadmill test and is simple and safe to use. However, allows the precise measurement of the functional in-
capacity experienced by the claudicant. It is safe andit still does not measure the actual incapacity that
claudicants suffer from on a day to day basis and it is simple to use and its results are not affected by observer
variation. The DEMPHY (Double Epreuve de Marchetherefore impossible to assess how a patients walking
Eur J Vasc Endovasc Surg Vol 22, December 2001
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Fig. 5. Scattergraph comparing the PADHOC initial claudication distance from the first part of the DPWT to the treadmill initial claudication
distance.
Table 3. Comparison of DPWT variables in patients who were and were not able to complete a standard treadmill test. Values are
represented as median (IQ ranges). Statistical analysis was performed using the Mann–Whitney U-test.
PADHOC variables Patients able to complete Patients unable to complete p-value
a treadmill test a treadmill test
Number of claudicants 49 14 —
ICD1 (metres) 126 (76–188) 57 (46–119) 0.02
MWD1 (metres) 270 (187–481) 107 (74–165) <0.01
Speed1 (km/h) 3.6 (3.0–3.8) 2.6 (1.9–3.2) <0.01
ICD2 (metres) 33 (4–108) 13 (6–39) 0.37
MWD2 (metres) 133 (85–278) 73 (43–125) 0.02
Speed2 (km/h) 3.5 (3.0–3.8) 2.7 (1.7–3) <0.01
Rest time between 64 (63–64) 64 (62–65) 0.96
tests 1 and 2 (s)
ICD ratio 0.34 (0.04–0.90) 0.27 (0.05–0.64) 0.82
MWD ratio 0.56 (0.39–0.82) 0.5 (0.41–0.70) 0.95
1 First part of the DPWT.
2 Second part of the DPWT.
Physiologique) study, an initial study that compared between treadmill walking distances and the walking
distances obtained for the DPWT in all variables exceptthe DPWT to treadmill testing showed that ICD and
MWD obtained form the treadmill test correlated posi- the ICD2 distance. This therefore confirms that the
PADHOC device accurately reflects walking distancestively with the values obtained form the PADHOC
device and that, the overall acceptability of the PAD- obtained from the treadmill test. Furthermore, we
also found a correlation between disease severity asHOC was significantly better than the treadmill test.11
In our study, the test was performed along a level determined by the SVS/ISCVS criteria and disease
severity as determined by the ratios of ICD and MWDcorridor within the hospital making the conditions
similar to those experienced by the claudicants on a from the DPWT. Thus the DPWT compares favourably
with the treadmill test, suggesting that the DPWTday-to day basis. The results obtained were therefore
more likely to reflect the functional incapacity ex- could replace the treadmill test as a measure of disease
severity.perienced by the patients in their daily lives.
In this study we have found strong correlation We also found that those patients who were unable
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